ÇELİKKAYA, B. Ç. Et Al. 2021. In silico Investigation of FDA-Approved Drugs Used in Gastrointestinal Tumours on Gastric Cancer Targets. 2. ULUSLARASI KANSER GÜNLERİ .

ÇELİKKAYA, B. Ç., ÇELİKKAYA, S. İ., & YAYLIM, İ., (2021). In silico Investigation of FDA-Approved Drugs Used in Gastrointestinal Tumours on Gastric Cancer Targets . 2. ULUSLARASI KANSER GÜNLERİ

ÇELİKKAYA, BEKİR, SÜMEYYE İDİL ÇELİKKAYA, And İLHAN YAYLIM. "In silico Investigation of FDA-Approved Drugs Used in Gastrointestinal Tumours on Gastric Cancer Targets," 2. ULUSLARASI KANSER GÜNLERİ, 2021

ÇELİKKAYA, BEKİR Ç. Et Al. "In silico Investigation of FDA-Approved Drugs Used in Gastrointestinal Tumours on Gastric Cancer Targets." 2. ULUSLARASI KANSER GÜNLERİ , 2021

ÇELİKKAYA, B. Ç. ÇELİKKAYA, S. İ. And YAYLIM, İ. (2021) . "In silico Investigation of FDA-Approved Drugs Used in Gastrointestinal Tumours on Gastric Cancer Targets." 2. ULUSLARASI KANSER GÜNLERİ .

@conferencepaper{conferencepaper, author={BEKİR ÇAĞLAR ÇELİKKAYA Et Al. }, title={In silico Investigation of FDA-Approved Drugs Used in Gastrointestinal Tumours on Gastric Cancer Targets}, congress name={2. ULUSLARASI KANSER GÜNLERİ}, city={}, country={}, year={2021}}